An Open Label, 2-Period, Sequential Study to Determine the Impact of Multiple Doses of Ketoconazole on Single-Dose Pharmacokinetics of HCV-796 [nesbuvir].
Phase of Trial: Phase I
Latest Information Update: 14 Jul 2009
At a glance
- Drugs Ketoconazole; Nesbuvir
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors Wyeth
- 14 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Apr 2008 Development of nesbuvir has been discontinued due to safety issues, according to a ViroPharma media release.
- 13 Oct 2006 New trial record.